glp-1 news today insurers coverage Does health insurance cover medications for diabetes and weight loss? GLP-1 insurance change impacts millions

Description

By developing this in-depth understanding of the impacts of the GLP-1s on patient populations, treatment paradigms and clinician messaging, MedTech companies will be able to make informed strategic decisions to stay the course or pivot to other promising segments if needed

Second, head-to-head comparative trials between GLP-1 RA monotherapy, dual agonists, and triple agonists in MASH populations with histological endpoints are entirely lacking: current selection among agents relies on indirect comparisons across trials with different inclusion criteria and follow-up periods

Tirzepatide activating both receptors simultaneously is why clinical trials show it outperforming semaglutide on average weight lost though both are clinically remarkable medications